The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders
Crossref DOI link: https://doi.org/10.3389/fncel.2016.00296
Published Online: 2017-01-04
Update policy: https://doi.org/10.3389/crossmark-policy
Johnson, M. Brittany
Young, Ada D.
Marriott, Ian
Funding for this research was provided by:
National Institutes of Health (R01 NS050325)